Kiwa Bio-Tech Products Group Corporation
KWBT · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $0 | $8 | $21 | $6 |
| - Cash | $0 | $0 | $1 | $0 |
| + Debt | $3 | $1 | $1 | $2 |
| Enterprise Value | $3 | $10 | $21 | $8 |
| Revenue | $40 | $31 | $17 | $10 |
| % Growth | 30.8% | 77.5% | 79.6% | – |
| Gross Profit | $9 | $8 | $5 | $2 |
| % Margin | 23.3% | 26.9% | 31.4% | 20.2% |
| EBITDA | -$1 | $3 | $2 | $2 |
| % Margin | -2.5% | 8.5% | 12.9% | 16.7% |
| Net Income | -$7 | $0 | $5 | $1 |
| % Margin | -16.6% | 1.1% | 30.7% | 10% |
| EPS Diluted | -0.29 | 0.021 | 0.43 | 0.09 |
| % Growth | -1,494.2% | -95.2% | 377.8% | – |
| Operating Cash Flow | $0 | -$2 | -$6 | -$1 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$2 | -$6 | -$1 |